Skip to content

13F-HR filed by Cormorant Asset Management, LP

Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 93 holding rows worth $2,600,688,000.

Accession
0001583977-20-000005
Filed
2020-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A holdings report, 93 entries on the cover page, a total value of $2,600,688,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,600,688,000 with VALUE read as thousands by filing date, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TURNING PT THERAPEUTICS90041T108COM2,442,297$213,359,000thousands by filing date
SPY78462F103SHS500,000$167,445,000thousands by filing dateput
FORMA THERAPEUTICS HLDGS INC34633R104SHS3,379,373$166,465,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock2,640,177$91,878,000thousands by filing date
BRIDGEBIO PHARMA INC10806X102COM2,265,762$85,011,000thousands by filing date
CHEMOCENTRYX INC16383L106COM1,400,000$76,720,000thousands by filing date
iShares Russell 2000 ETF464287655SHS500,000$74,895,000thousands by filing dateput
AVIDITY BIOSCIENCES INC COM05370A108Stock2,514,546$69,538,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK6,000,000$66,900,000thousands by filing date
MYOKARDIA INC62857M105COM450,000$61,349,000thousands by filing date
IMMUNOVANT INC45258J102COM1,637,951$57,639,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM1,866,108$56,300,000thousands by filing date
ACCELERON PHARMA INC00434H108COM500,000$56,265,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH500,000$55,715,000thousands by filing dateput
Y-mAbs Therapeutics Inc984241109Common Stock1,397,700$53,658,000thousands by filing date
ZYMEWORKS INC98985W102COM1,150,000$53,567,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM1,537,807$51,501,000thousands by filing date
OMEROS CORP682143102COM5,000,000$50,525,000thousands by filing date
EIDOS THERAPEUTICS INC.28249H104Common Stock993,185$50,186,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM275,000$45,664,000thousands by filing date
VIELA BIO INC.926613100Common Stock1,585,000$44,507,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A450,000$43,839,000thousands by filing date
TWIST BIOSCIENCE CORP90184D100COM500,000$37,985,000thousands by filing date
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK971,770$35,959,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock2,500,000$35,525,000thousands by filing date
AXONICS INC05465P101COM693,000$35,371,000thousands by filing date
AGENUS INC00847G705COM NEW8,500,000$34,000,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM500,000$32,505,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM1,368,550$31,285,000thousands by filing date
ARCTURUS THERAPEUTICS HLDGS03969T109COM700,000$30,030,000thousands by filing date
MYOVANT SCIENCES LTDG637AM102COMMON STOCK-FO2,134,966$29,996,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM859,550$26,466,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM275,000$25,493,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock300,000$25,092,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK700,000$23,359,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR325,000$22,410,000thousands by filing date
CABALETTA BIO INC12674W109COMMON STOCK2,067,302$22,410,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM796,428$19,608,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR125,000$19,290,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR130,000$18,471,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock250,000$17,813,000thousands by filing date
IGM BIOSCIENCES INC449585108COM225,000$16,607,000thousands by filing date
ZAI LAB LTD ADR98887Q104ADR189,092$15,727,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock120,000$15,486,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock500,000$15,320,000thousands by filing date
CHEMOCENTRYX INC16383L106COM250,000$13,700,000thousands by filing datecall
PLIANT THERAPEUTICS INC729139105COM611,409$13,571,000thousands by filing date
OTONOMY INC68906L105COM3,241,800$13,129,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM250,000$12,825,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM600,000$12,192,000thousands by filing date
UNIQURE NVN90064101SHS325,000$11,970,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM85,000$11,937,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock350,000$11,249,000thousands by filing date
AKOUOS INC00973J101COM499,991$11,206,000thousands by filing date
REPARE THERAPEUTICS INC760273102COM348,567$10,725,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR40,000$10,501,000thousands by filing date
QUOTIENT LTDG73268107SHS2,000,000$10,280,000thousands by filing date
OMEROS CORP682143102COM1,000,000$10,110,000thousands by filing datecall
HARPOON THERAPEUTICS INC41358P106COM570,600$9,694,000thousands by filing date
THERAVANCE BIOPHARMA INCG8807B106COM650,072$9,611,000thousands by filing date
ANAPTYSBIO INC032724106COM650,000$9,588,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS800,000$8,800,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM350,000$8,635,000thousands by filing date
BCTG ACQUISITION CORP05492W103COM800,000$8,365,000thousands by filing date
PROTARA THERAPEUTICS INC74365U107COM STK450,000$7,574,000thousands by filing date
THERAPEUTICS ACQUISITION COR88339T103COM CL A500,000$7,190,000thousands by filing date
MORPHIC HLDG INC61775R105COM250,000$6,835,000thousands by filing date
TRICIDA INC89610F101COM727,975$6,595,000thousands by filing date
ALLAKOS INC01671P100COM75,000$6,109,000thousands by filing date
GENETRON HLDGS LTD37186H100ADS500,000$5,970,000thousands by filing date
AVEO PHARMACEUTICALS INC053588307COM1,000,000$5,940,000thousands by filing date
FS DEV CORP303020101COM CL A500,000$5,599,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK500,000$5,575,000thousands by filing datecall
MERUS N VN5749R100COM429,284$5,151,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM470,897$5,039,000thousands by filing date
AUTOLUS THERAPEUTICS PLC SPON05280R100COM422,167$4,914,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM931,800$4,510,000thousands by filing date
VESPER HEALTHCARE ACQSTN COR92538T203UNIT 99/99/9999400,000$4,104,000thousands by filing date
ATRECA INC04965G109COM293,500$4,100,000thousands by filing date
KADMON HLDGS INC48283N106COM1,000,000$3,920,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM449,510$3,659,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock244,032$3,177,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock248,382$3,082,000thousands by filing date
PANACEA ACQUISITION CORP698102209UNIT 99/99/9999250,000$3,000,000thousands by filing date
CARDIFF ONCOLOGY INC14147L108COM175,000$2,483,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW30,000$2,244,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM346,524$2,135,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW300,000$1,263,000thousands by filing date
ORCHARD THERAPEUTICS PLC68570P101ADR256,649$1,055,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM50,000$830,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock238,817$759,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM15,000$600,000thousands by filing date
OUTLOOK THERAPEUTICS INC69012T115*W EXP 02/18/202416,666$54,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001583977-20-000005this filing2020-11-16acceptance time not in the bulk data set